Target intelligence / Profile preview

Hepatocellular calcium-linked exocytosis machinery

Molecular classification
Protein complex, SNARE complex, Calcium-binding proteins, GTPases
01

Overview

The hepatocellular calcium-linked exocytosis machinery is a complex system of proteins responsible for the regulated secretion of bile acids, proteins, and lipids from hepatocytes into the bile canaliculi or the bloodstream [PMID: 11514514]. This process is primarily triggered by increases in intracellular calcium concentrations ([Ca2+]i), often mediated by inositol 1,4,5-trisphosphate (IP3) receptors and purinergic signaling [PMID: 7513305]. Key molecular components include SNARE proteins such as Syntaxin 2, SNAP-23, and VAMP8, which facilitate membrane fusion, as well as calcium sensors like Synaptotagmin VII [PMID: 17606460]. Dysregulation of this machinery is a hallmark of various liver diseases, particularly cholestasis, where impaired exocytosis leads to the toxic accumulation of bile acids within hepatocytes [PMID: 12851210]. Therapeutic agents like ursodeoxycholic acid (UDCA) are known to stimulate this machinery by enhancing calcium signaling, thereby promoting biliary secretion and providing hepatoprotection [PMID: 8381124]. Because this term describes a multi-protein physiological process rather than a single molecular entity, it is classified as a machinery or pathway rather than a discrete therapeutic target.

Other names
Hepatocyte exocytic apparatusCalcium-dependent hepatocyte secretionHepatocellular SNARE-mediated exocytosisBiliary exocytotic machinery
02

Mechanism of action

Modulation of intracellular calcium transients and activation of calcium-sensitive proteins (e.g., Synaptotagmin VII) to promote the assembly of SNARE complexes and subsequent vesicle fusion with the canalicular membrane.

03

Biological functions

ExocytosisBile secretionProtein transportCalcium signalingVesicle fusionIntracellular trafficking
04

Disease associations

CholestasisNonalcoholic fatty liver disease (NAFLD)Liver cirrhosisHyperbilirubinemiaBiliary atresia
05

Safety considerations

Potential for systemic off-target effects on exocytosis in other tissues (e.g., neurotransmission)Risk of calcium signaling overload leading to apoptosisDisruption of non-target protein trafficking pathways
06

Interacting drugs

Ursodeoxycholic acid (UDCA)

3 more in the full profile.

07

Biomarkers

Serum bile acidsTotal bilirubinAlkaline phosphatase (ALP)Gamma-glutamyl transferase (GGT)

Beyond the preview

Go deeper on Hepatocellular calcium-linked exocytosis machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatocellular calcium-linked exocytosis machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call